A Phase I Study of AZD4635 in Japanese Patients With Advanced Solid Malignancies
Status:
Completed
Trial end date:
2020-09-07
Target enrollment:
Participant gender:
Summary
This is a Phase I, open-label study to assess the safety, tolerability, pharmacokinetics and
anti-tumor activity of AZD4635 in Japanese patients with advanced solid malignancies. This
study consists of 2 cohorts, Cohort1 and Cohort2. At least 3 or up to 6 evaluable Japanese
patients with advanced solid malignancies will be enrolled in Cohort1 and 6 evaluable
patients will be enrolled in Cohort2.